Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Herpes simplex infections].

W Kimmig1

  • 1Universitäts-Hautklinik und Poliklinik Hamburg.

Zeitschrift Fur Hautkrankheiten
|April 15, 1989
PubMed
Summary
This summary is machine-generated.

Current herpes simplex virus treatments are insufficient, particularly for recurrent infections and immunocompromised individuals. New vaccine development holds promise for future prophylactic herpes simplex therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Side effects and complications of therapy with laser and intense light sources].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2013
Same author

[Side effects of therapy with flashlamps and lasers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2008
Same author

[Laser boom in Germany. Who guarantees quality? (interview by Dr. med. Horst Gross)].

MMW Fortschritte der Medizin·2007
Same author

[Laser surgery in dermatology. Risks and chances].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2003
Same author

[Laser therapy in dermatology and esthetic medicine. Side effects, complications and treatment errors].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2000
Same author

Topical cyclosporine in chronic benign familial pemphigus (Hailey-Hailey disease).

Journal of the American Academy of Dermatology·1992
Same journal

[Acne vulgaris: morphologic, endocrinologic and psychosomatic aspects].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[Anti-androgen treatment of hirsutism with cyproterone acetate].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[Changes in sunscreening products in West Germany between 1988 and 1989/90].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[Effect of treatment with salt from the Dead Sea (Tomesa therapy) on epidermal Langerhans cells--a clinical study].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[DNA determination by cytophotometry in bowenoid papules in comparison with condylomata acuminata and Bowen's disease].

Zeitschrift fur Hautkrankheiten·1990
Same journal

[Adverse drug reactions on hair].

Zeitschrift fur Hautkrankheiten·1990
See all related articles

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Context:

  • Herpes simplex virus (HSV) infections present ongoing therapeutic challenges despite available antiviral medications.
  • Recurrent HSV infections and protecting immunocompromised patients remain significant unmet medical needs.
  • Existing vaccination strategies for HSV have shown limited success, as evidenced by a multicenter study on an envelope antigen vaccine.

Purpose:

  • To evaluate the efficacy of current treatments for herpes simplex infections.
  • To identify challenges in managing recurrent HSV infections and protecting vulnerable populations.
  • To assess the potential of novel vaccine candidates for herpes simplex prophylaxis.

Summary:

  • Modern antiviral drugs offer limited efficacy in managing herpes simplex virus infections.

Related Experiment Videos

  • Neither recurrent infections nor the protection of immunocompromised patients are adequately addressed by current therapies.
  • A multicenter study indicated that a new herpes simplex virus envelope antigen vaccine is not promising for preventing infections.

    • Impact:

    • There is a critical need for improved therapeutic and prophylactic strategies against herpes simplex virus.
    • Future advancements in genetic engineering may lead to effective vaccines for preventing herpes simplex.
    • Development of new vaccines could significantly impact the prophylactic treatment of herpes simplex infections.